Advertisement

Smoking in pregnancy and lactation: a review of risks and cessation strategies

  • Adrienne Einarson
  • Sara Riordan
Review Article

Abstract

Background

Despite documented evidence of harm to fetus and infant, a substantial number of women continue to smoke during pregnancy and lactation.

Objective

To examine the literature regarding smoking during pregnancy and breastfeeding to ascertain adverse effects as well as the efficacy of interventions to enable women to stop smoking in the perinatal period.

Study design

A comprehensive literature search was undertaken to identify all published studies reporting on smoking in pregnancy and lactation. MEDLINE, EMBASE, PUBMED, and Web of Science databases were searched for studies published in English from 1966 to 2008 that reported on smoking in pregnancy and breastfeeding, with information on adverse effects and on all forms of smoking cessation, including behavioral interventions, nicotine replacement therapy, and pharmacotherapy such as antidepressants.

Results

There is evidence that smoking in pregnancy and lactation may cause many adverse affects in the perinatal period, childhood, and up to adulthood. These adverse effects include infertility, ectopic pregnancy, spontaneous abortion, placenta insufficiency, low birth weight, fetal growth restriction, preterm delivery, orofacial clefts, SIDS, craniosynostosis, clubfoot, childhood respiratory disease, attention deficit disorder, and some childhood cancers. A number of strategies have been developed to assist pregnant women in quitting smoking, including both behavioral interventions and pharmacological therapies, such as nicotine replacement and antidepressant therapy.

Conclusions

Behavioral interventions report only modest success rates. Nicotine replacement therapy and antidepressants appear to be safe to use in pregnancy, but do not achieve a substantially higher success rate for quitting.

Keywords

Smoking Pregnancy Nicotine Cessation 

References

  1. 1.
    Thielen A, Klus H, Müller L (2008) Tobacco smoke: unraveling a controversial subject. Exp Toxicol Pathol 60(2–3):141–156PubMedCrossRefGoogle Scholar
  2. 2.
    Lambers DS, Clark KE (1996) The maternal and fetal physiologic effects of nicotine. Semin Perinatol 20(2):115–126PubMedCrossRefGoogle Scholar
  3. 3.
    U.S. Department of Health and Human Services (2002) Health, United States, with chart books and trends in the health of Americans (DHHS Publication No. 1232). U.S Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MDGoogle Scholar
  4. 4.
    Sardu C, Mereu A, Pitzalis G, Minerba L, Contu P (2006) Smoking trends in Italy from 1950–2000. J Epidemiol Commmunity Health 60(9):799–803CrossRefGoogle Scholar
  5. 5.
    National Board of Health Denmark (2002) Survey of smoking habits in Denmark 2002. National Board of Health Denmark, CopenhagenGoogle Scholar
  6. 6.
    Statistics Sweden (2002) Swedish survey of living conditions. Statistics Sweden, StockholmGoogle Scholar
  7. 7.
    Mohsin M, Bauman AE (2005) Socio-demographic factors associated with smoking and smoking cessation among 426,344 pregnant women in New South Wales, Australia. BMC Public Health 5:138PubMedCrossRefGoogle Scholar
  8. 8.
    Jensen KE, Jensen A, Nohr B, Kruger-Kjaer S (2008) Do pregnant women still smoke? A study of smoking patterns among 261,029 primiparous women in Denmark 1997–2005. Acta Obstet Gynecol 87:760–767CrossRefGoogle Scholar
  9. 9.
    Jaakkola N, Jaakkola MS, Gissler M, Jaakkola JJ (2001) Smoking during pregnancy in Finland: determinants and trends, 1987–1997. Am J Public Health 91(2):284–286PubMedCrossRefGoogle Scholar
  10. 10.
    Baska T, Sovinova H, Nemeth A, Przewozniak K, Warren C, Kavcova E (2006) Czech Republic, Hungary, Poland and Slovakia GYTS Collaborative Group. Findings from the Global Youth Tobacco Survey (GYTS) in Czech Republic, Hungary, Poland and Slovakia – smokig initiation, prevalence of tobacco use and cessation. Soz Praventiv Med 51:110–116CrossRefGoogle Scholar
  11. 11.
    Perlman F, Bobak M, Gilmore A, McKee M (2007) Trends in the prevalence of smoking in Russia during the transition to a market economy. Tob Control 16(5):299–305PubMedCrossRefGoogle Scholar
  12. 12.
    Andreeva TI, Krasovsky KS (2007) Changes in smoking prevalence in Ukraine in 2001-5. Tob Control 16(3):202–206PubMedCrossRefGoogle Scholar
  13. 13.
    Cnattingius S (2004) The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6(Suppl 2):S125–S140PubMedCrossRefGoogle Scholar
  14. 14.
    Goodwin RD, Keyes K, Simuro N (2007) Mental disorders and nicotine dependence among pregnant women in the United States. Obstet Gynecol 109(4):875–883PubMedGoogle Scholar
  15. 15.
    Kelly-Weeder S, Cox CL (2006) The impact of lifestyle risk factors on female infertility. Women Health 44(4):1–23PubMedGoogle Scholar
  16. 16.
    Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML (1999) Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med 16(3):208–215PubMedCrossRefGoogle Scholar
  17. 17.
    Shea AK, Steiner M (2008) Cigarette smoking during pregnancy. Nicotine Tob Res 10(2):267–278PubMedCrossRefGoogle Scholar
  18. 18.
    Jauniaux E, Burton GJ (2007) Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev 83(11):699–706PubMedCrossRefGoogle Scholar
  19. 19.
    Collet M, Beillard C (2005) Consequences of smoking on fetal development and risk of intra-uterine growth retardation or in utero fetal death. J Gynecol Obstet Biol Reprod (Paris) 34 (Spec No 1):3S135-45Google Scholar
  20. 20.
    Shah NR, Bracken MB (2000) A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 182(2):465–472PubMedCrossRefGoogle Scholar
  21. 21.
    Little J, Cardy A, Munger RG (2004) Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Org 82(3):213–218PubMedGoogle Scholar
  22. 22.
    Mitchell EA, Milerad J (2006) Smoking and the sudden infant death syndrome. Rev Environ Health 21(2):81–103PubMedGoogle Scholar
  23. 23.
    Kallen K (1999) Maternal smoking and craniosynostosis. Teratology 60(3):146–150PubMedCrossRefGoogle Scholar
  24. 24.
    Skelly AC, Holt VL, Mosca VS, Alderman BW (2002) Talipes equinovarus and maternal smoking: a population-based case-control study in Washington state. Teratology 66(2):91–100PubMedCrossRefGoogle Scholar
  25. 25.
    Carlsen KH, Carlsen KC (2008) Respiratory effects of tobacco smoking on infants and young children. Paediatr Respir Rev 9(1):11–19PubMedCrossRefGoogle Scholar
  26. 26.
    Langley K, Rice F, van den Bree MB, Thapar A (2005) Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr 57(6):359–371Google Scholar
  27. 27.
    Bluhm EC, Daniels J, Pollock BH, Olshan AF (2006) Children’s Oncology Group (United States). Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children’s Oncology Group (United States). Cancer Causes Control 17(5):663–669PubMedCrossRefGoogle Scholar
  28. 28.
    Matheson I, Rivrud GN (1989) The effect of smoking on lactation and infantile colic. JAMA 261(1):42–43PubMedCrossRefGoogle Scholar
  29. 29.
    Hopkinson JM, Schanler RJ, Garza C (1992) Milk production by mothers of premature infants. Influence of cigarette smoking. Pediatrics 90(6):934–938PubMedGoogle Scholar
  30. 30.
    Ilett KF, Hale TW, Page-Sharp M, Kristensen JH, Kohan R, Hackett LP (2003) Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther 74(6):516–524PubMedCrossRefGoogle Scholar
  31. 31.
    Amir LH (2001) Maternal smoking and reduced duration of breastfeeding: a review of possible mechanisms. Early Hum Dev 64(1):45–67PubMedCrossRefGoogle Scholar
  32. 32.
    Pbert L, Ockene JK, Zapka J, Ma Y, Goins KV, Oncken C, Stoddard AM (2004) A community health center smoking-cessation intervention for pregnant and postpartum women. Am J Prev Med 26(5):377–385PubMedCrossRefGoogle Scholar
  33. 33.
    Lumley J, Oliver SS, Chamberlain C, Oakley L (2004) Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev (4):CD001055Google Scholar
  34. 34.
    Lawrence T, Aveyard P, Cheng KK, Griffin C, Johnson C, Croghan E (2005) Does stage-based smoking cessation advice in pregnancy result in long-term quitters? An 18-month postpartum follow-up of a randomized controlled trial. Addiction 100(1):107–116PubMedCrossRefGoogle Scholar
  35. 35.
    Rigotti NA, Park ER, Regan S, Chang Y, Perry K, Loudin B, Quinn V (2006) Efficacy of telephone counseling for pregnant smokers: a randomized controlled trial. Obstet Gynecol 108(1):83–92PubMedGoogle Scholar
  36. 36.
    Schnoll RA, Patterson F, Lerman C (2007) Treating tobacco dependence in women. J Womens Health (Larchmt) 16(8):1211–1218CrossRefGoogle Scholar
  37. 37.
    Cnattingius S, Akre O, Lambe M, Ockene J, Granath F (2006) Will an adverse pregnancy outcome influence the risk of continued smoking in the next pregnancy? Am J Obstet Gynecol 195(6):1680–1686PubMedCrossRefGoogle Scholar
  38. 38.
    Dempsey D, Jacob P 3rd, Benowitz NL (2002) Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 301(2):594–598PubMedCrossRefGoogle Scholar
  39. 39.
    Chan B, Einarson A, Koren G (2005) Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis 24(2):19–23PubMedCrossRefGoogle Scholar
  40. 40.
    Kapur B, Hackman R, Selby P, Klein J, Koren G (2001) Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res 62(4):274–278CrossRefGoogle Scholar
  41. 41.
    Hotham ED, Atkinson ER, Gilbert AL (2002) Focus groups with pregnant smokers: barriers to cessation, attitudes to nicotine patch use and perceptions of cessation counseling by care providers. Drug Alcohol Rev 21:163–168PubMedCrossRefGoogle Scholar
  42. 42.
    Schroeder DR, Ogburn PL Jr, Hurt RD, Croghan IT, Ramin KD, Offord KP, Moyer TP (2002) Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J Matern Fetal Neonatal Med 11(2):100–107PubMedCrossRefGoogle Scholar
  43. 43.
    Wisborg K, Henriksen TB, Jespersen LB, Secher NJ (2000) Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96(6):967–971PubMedCrossRefGoogle Scholar
  44. 44.
    Haggstram FM, Chatkin JM, Sussenbach-Vaz E, Cesari DH, Fam CF, Fritscher CC (2006) A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. Pulm Pharmacol Ther 19(3):205–209PubMedCrossRefGoogle Scholar
  45. 45.
    Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S (2007) A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care. Arch Intern Med 167(16):1791–1797PubMedCrossRefGoogle Scholar
  46. 46.
    Berlin I, Said S, Spreux-Varoquaux O, Launay JM, Olivares R, Millet V, Lecrubier Y, Puech AJ (1995) A reversible monoamine oxidase. A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 58(4):444–452PubMedCrossRefGoogle Scholar
  47. 47.
    Hughes JR, Stead LF, Lancaster T (2007) Antidepressants for smoking cessation. Cochrane Database Syst Rev (1):CD000031Google Scholar
  48. 48.
    U.S. Food and Drug Administration Center for Drug Evaluation and Research (1997) Zyban® (bupropion) label and approval history. http://www.fda.gov/cder/drugsatfda/datafiles/default.htm. Accessed 18 Nov 2007
  49. 49.
    Chun-Fai-Chan B, Koren G, Fayez I et al (2005) Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192(3):932–936PubMedCrossRefGoogle Scholar
  50. 50.
    Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM (2007) Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 16(5):474–484PubMedCrossRefGoogle Scholar
  51. 51.
    Murphy MF, Hey K, Johnstone E, Munafo M, Walton R, Willis B, Harrison PJ (2002) Bromocriptine use is associated with decreased smoking rates. Addict Biol 7(3):325–328PubMedCrossRefGoogle Scholar
  52. 52.
    Krupp P, Monka C (1987) Bromocriptine in pregnancy: safety aspects. J Molec Med 65(17):823–827Google Scholar
  53. 53.
    Stack NM (2007) Smoking cessation: an overview of treatment options with a focus on varenicline. Pharmacotherapy 27(11):1550–1557PubMedCrossRefGoogle Scholar
  54. 54.
    Tutka P, Zatonski W (2006) Cytisine for the treatment of nicotine addiction: from molecule to therapeutic efficacy. Pharmacol Rep 58(6):777–798PubMedGoogle Scholar
  55. 55.
    Murtagh J, Foerster V (2007) Nicotine vaccines for smoking cessation. Issues Emerg Health Technol 103:1–4Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.The Motherisk Program, The Hospital for Sick Children, Division of Clinical PharmacologyUniversity of TorontoTorontoCanada
  2. 2.Arizona Teratology Information ProgramTucsonUSA

Personalised recommendations